SuperworthBionano Genomics market cap BNGO
Share price times shares outstanding: what the whole company sells for, since 2018.
- Today, Oct 23, 2026
- $13.3M
- Highest close in our data
- $2.2B
- Apr 2021
Bionano Genomics is worth $13.3M at the close on Oct 23, 2026, at $1.13 a share.
That is up 47% over the last year and down 99% over five years.
Its highest close in our data was $2.2B in Apr 2021.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $13.3M | $11.2M | $20.4M | −14% |
| 2025 | $15.5M | $4.9M | $32.3M | −28% |
| 2024 | $21.4M | $19.9M | $76.2M | −71% |
| 2023 | $73.4M | $44.5M | $555.2M | −83% |
| 2022 | $433.5M | $388.2M | $1B | −50% |
| 2021 | $864.7M | $720M | $2.2B | +83% |
| 2020 | $471.8M | $10.4M | $471.8M | +1549% |
| 2019 | $28.6M | $6.4M | $50.5M | −42% |
| 2018 | $49.2M | $49.2M | $72.2M | n/a |
Against its peers
Companies in Healthcare nearest Bionano Genomics' size, closest first, today.
| Company | Market cap |
|---|---|
| BNGOBionano Genomics | $13.3M |
| NEPHNephros | $38.3M |
| ATNMActinium Pharmaceuticals | $47.8M |
| APTAlpha Pro Tech | $56.7M |
| SPROSpero Therapeutics | $64.6M |
| LFVNLifevantage | $73.4M |
| ICCCImmucell | $93.1M |
| KEQUKewaunee Scientific | $94.9M |
| Peer median | $64.6M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Bionano Genomics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.